3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia, Myeloid, Acute
5
Lymphoma, Non-Hodgkin
3
Triple Negative Breast Neoplasms
2
Multiple Myeloma
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Lymphoma
2
Glioblastoma
2
Burkitt Lymphoma
2
Sarcoma, Synovial
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neuroblastoma
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Liposarcoma, Myxoid
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Hematologic Diseases
1
Ganglioneuroblastoma
1
Fallopian Tube Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Astrocytoma
1
Interventions
Cyclophosphamide
26
fludarabine
18
Dexamethasone
17
pembrolizumab
12
Rituximab
11
Etoposide
10
venetoclax
9
pomalidomide
9
Gemcitabine
9
fludarabine phosphate
7
daratumumab
7
Lenalidomide
7
Bortezomib
7
carfilzomib
6
obinutuzumab
5
glofitamab
5
Vincristine
5
Temozolomide
5
Prednisone
5
Nivolumab
5
Immunotherapy, Adoptive
5
Cisplatin
5
Calcium Dobesilate
5
selinexor
4
cemiplimab
4
Doxorubicin
4
Cytarabine
4
Carboplatin
4
zanubrutinib
3
ruxolitinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Leukapheresis
×
90 days
×
Clear all
No trials found.